• S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?

  • Apr 25 2023
  • Length: 26 mins
  • Podcast

S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?

Listen for free

View show details

  • Summary

  • Dr Steve Feldman speaks with Drs Mehta, Ritchlin, and Fried who share an exciting new roadmap for calming key psoriasis comorbidities.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986151). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-rich Necrotic Core: Results From a Prospective, Observational Study https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.120.011199

    Treating the Skin With Biologics in Patients With Psoriasis Decreases the Incidence of Psoriatic Arthritis https://pubmed.ncbi.nlm.nih.gov/34281904/

    The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener https://pubmed.ncbi.nlm.nih.gov/14583691/
    Show more Show less
Show more Show less

What listeners say about S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available